Rafael Holdings, Inc.
Trappsol Cyclo
Niemann-Pick Disease Type C
Resolved
27days ago
Phase 3 readout · Jun 10, 2026
What's at stake
Phase 3 trial results for Trappsol Cyclo in Niemann-Pick Disease Type C are due Jun 10, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“topline results are expected to be announced in second half of calendar 2026”